Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature

被引:52
作者
Johnson, EIM [1 ]
Dunlop, ME [1 ]
Larkins, RG [1 ]
机构
[1] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia
关键词
arachidonic acid; diabetic retinopathy; prostaglandins; retinal vasculature; streptozotocin-diabetic rat;
D O I
10.1076/ceyr.18.2.79.5386
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. This study was undertaken in order to investigate whether the production of vasodilatory prostaglandins is increased in the retinal vasculature of the diabetic rat. Methods. Diabetes was induced in male Sprague-Dawley rats using streptozotocin. Diabetic rats were left uncontrolled for 3-4 weeks or were treated with insulin replacement throughout the period of diabetes. Control rats were age-matched. Retinal vessels extracted from retinae removed at sacrifice were incubated in a physiological salts solution. Prostaglandin E and prostaglandin I-2 were measured in collected medium. Results. The production of both prostaglandin E and prostaglandin I-2 by blood vessels isolated from the retina was increased by approximately 40% in streptozotocin-diabetic rats, compared to controls, within 4 weeks of the onset of diabetes. This increase was reversed by treatment of streptozotocin-diabetic rats with insulin. The increase in prostaglandin production was not due to alteration in the maximal capacity of cyclooxygenase enzyme. Conclusions. Increased production of vasodilatory prostaglandins occurs in the rat retinal vasculature early in diabetes. Prostaglandins may contribute to altered retinal hemodynamics in early diabetic retinopathy.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 14 条
  • [1] MECHANISMS OF THE BIPHASIC EFFECTS OF PEROXIDES ON THE RETINAL VASCULATURE OF NEWBORN AND ADULT-PIGS
    ABRAN, D
    HARDY, P
    VARMA, DR
    CHEMTOB, S
    [J]. EXPERIMENTAL EYE RESEARCH, 1995, 61 (03) : 285 - 292
  • [2] Diabetic retinopathy: Early functional changes
    Alder, VA
    Su, EN
    Yu, DY
    Cringle, SJ
    Yu, PK
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10) : 785 - 788
  • [3] Bursell SE, 1996, INVEST OPHTH VIS SCI, V37, P886
  • [4] CEFALU WT, 1994, CLIN CHEM, V40, P1317
  • [5] ROLE OF ENHANCED ARACHIDONATE AVAILABILITY THROUGH PHOSPHOLIPASE-A2 PATHWAY IN MEDIATION OF INCREASED PROSTAGLANDIN SYNTHESIS BY GLOMERULI FROM DIABETIC RATS
    CRAVEN, PA
    PATTERSON, MC
    DERUBERTIS, FR
    [J]. DIABETES, 1988, 37 (04) : 429 - 435
  • [6] CRINGLE SJ, 1993, INVEST OPHTH VIS SCI, V34, P1716
  • [7] PURIFICATION AND CHARACTERIZATION OF METABOLICALLY ACTIVE CAPILLARIES OF THE BLOOD-BRAIN-BARRIER
    DALLAIRE, L
    TREMBLAY, L
    BELIVEAU, R
    [J]. BIOCHEMICAL JOURNAL, 1991, 276 : 745 - 752
  • [8] Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
    Ishii, H
    Jirousek, MR
    Koya, D
    Takagi, C
    Xia, P
    Clermont, A
    Bursell, SE
    Kern, TS
    Ballas, LM
    Heath, WF
    Stramm, LE
    Feener, EP
    King, GL
    [J]. SCIENCE, 1996, 272 (5262) : 728 - 731
  • [9] Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A(2) activation
    Keogh, RJ
    Dunlop, ME
    Larkins, RG
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (01): : 41 - 47
  • [10] Larkins R G, 1996, Aust N Z J Ophthalmol, V24, P97, DOI 10.1111/j.1442-9071.1996.tb01561.x